Arsenic trioxide and all-trans retinoic acid treatment for acute promyelocytic leukaemia in all risk groups (AML17): results of a randomised, controlled, phase 3 trial
- Alan K Burnett
- , Nigel H Russell
- , Robert K Hills
- , David Bowen
- , Jonathan Kell
- , Steve Knapper
- , Yvonne G Morgan
- , Jennie Lok
- , Angela Grech
- , Gail Jones
- , Asim Khwaja
- , Lone Friis
- , Mary Frances McMullin
- , Ann Hunter
- , Richard E Clark
- , David Grimwade
- , UK National Cancer Research Institute Acute Myeloid Leukaemia Working Group
Research output: Contribution to journal › Article › peer-review
513
Link opens in a new tab
Citations
(Scopus)